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Hormone-receptor complexes are rather long 
lived allowing several discrete cycles of activation and 
deactivation of adenylate cyclase. Regulatory steps 
are therefore postulated facilitating dissociation of 
the hormone-receptor complex and modulating 
coupling between receptor and adenylate cyclase. 
1. Hormone receptors and adenylate cyclase 
At present the translation of hormone-receptor 
interactions into biological action is not understood. 
An important, although not universal action which is 
elicited by the interaction of the hormone with its 
receptor is the activation of adenylate cyclase. Some 
hormones, among them epinephrine, glucagon and 
ACTH, have been shown to act primarily through the 
product of the adenylate cyclase reaction, the 
second messenger cyclic 3’, 5’-AMP, but some 
biological effects may not be mediated by cyclic 
3’, 5’-AMP [l] . In any event, the interaction of 
hormones with receptors activates in some cases 
adenylate cyclase but initiates in all cases the 
biological response. It is therefore necessary to 
understand the translation of hormone-receptor 
interactions in order to comprehend the function 
of hormones. 
2. The lifetime of hormone-receptor complexes 
We have recently summarized the evidence from 
the literature on the lifetime of hormone-receptor 
complexes, cf [2] . 
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The ‘on’ constants (k,) of the insulin-receptor complex 
range between 5 X 10’ and 1.5 X 10’ mol-’ set-’ and the 
‘off constants (k_, ) range between 1 X lo-’ and 
3 X 10e4 set-’ Kass = k, /k_ , of the insulin-receptor 
complex and ranges therefore between 5 X 10”’ and 
5 X 10” M“ , cf [ 3 1. Thus, the insulin-receptor complex 
is a tight complex with an accordingly long lifetime. 
Assuming that dissociation of the hormone-receptor 
complex [H] . [R] -t [H] + [k] is first order, r/2 = 1 n 2/k_ , 
may be calculated; it ranged from 15.6 to 42.8 min at 24°C. 
Insulin actions on adenylate cyclase are doubtful; but 
similar data have recently been published on neurohypophy- 
seal hormones and membranes from bovine renal medulla. 
In contrast to insulin important biological actions of 
these hormones are transmitted via adenylate cyclase 
activation and 3’. 5’-CAMP. I:or vasopressin k, = 3.2 X lo6 
mol-’ sec.’ and k --I = 7.0 X 10.’ set-’ and Kass = 4.5 X 10’ 
M“ 141. (In a more recent study a K,,, value of 5 X lo9 M-’ 
was reported 151). Thus, the lifetime oi‘the vasopressin-receptor 
complex is likewise in the minute range as appears also to 
be the case for the &capon-receptor complex [6). 
These data raise doubts whether hormone-receptor 
interactions can control the rate of activation and 
deactivation, because several discrete cycles of 
activation and deactivation of adenylate cyclase 
could occur during the relative long occupancy of the 
receptor by the hormone. Thus, one should 
consider means for facilitating and enhancing the 
dissociation of the complex. One would like to 
know therefore how the hormone-receptor 
interaction can be modulated and moreover, what 
factors might control the coupling reaction between 
the liganded hormone-receptor complex and 
adenylate cyclase in the membrane. Evidence for 
independent regulation of both steps bears also on 
the structural and functional relationships of 
hormone receptor and adenylate cyclase. First, the 
control of the hormone receptor interaction is 
discussed. 
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3. Negative co-operativity 
There is evidence that some hormone binding 
sites, i.e.: for insulin [7] and catecholamines [8] 
may interact with each other, although other 
plausible explanations of apparent nonlinearity in 
Scatchard plots need seriously to be considered [9]. 
The reverse has also been described, namely that 
non-interacting mutually independent hormone 
binding sites activate adenylate cyclase in a co-operative 
manner [5] . Both situations imply nonlinear 
coupling. But if there is more than one hormone 
binding site involved in adenylate cyclase activation 
the possibility should be entertained that hormone 
receptors form clusters. These clusters could be 
inherent features of cell surface structures or they 
might be formed temporarily on binding of hormones 
to mobile receptors as has recently been suggested for 
cholera toxin bound to ganglioside G,, [lo] . 
Recent experiments of Dr Pierre De Meyts and 
colleagues, cf [ 1 I], with lymphocytes in culture and 
liver plasma membranes suggest hat the binding 
domains of insulin and of the receptor responsible 
for the biological effects of the hormone and those 
involved in negative co-operative interactions may 
be different. In a study with several insulin 
analogues the region of the insulin molecule 
responsible for the co-operative interaction was 
mapped. It was concluded that this site is covered 
by dimerisation of insulin, accounting for the fact 
that at high concentrations when insulin dimerizes 
negative co-operativity disappears. Insulin dimers are 
biologically active hence they still must bind to 
receptors but the insulin-dimer receptor complexes 
no longer interact co-operatively*. Concanavalin A 
does not bind to the activating site on insulin 
receptors but prevents negative co-operative inter- 
actions. This lectin is known to affect the 
distribution of cell surface components suggesting 
that the redistribution of hormone receptors could 
play a role in negative co-operativity. 
Growth hormone and the neurohypophyseal 
hormones, vasopressin and oxytocin act differently: 
* To the contary, Cuatrecasas and Hollenberg [ 12 ] make 
self-aggregation responsible for non-linear Scatchard plots of 
binding data obtained from competition-displacement 
experiments. 
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Roy, Barth and Jard [S] have recently tested a number 
of vasopressin analogues on pig kidney plasma membranes for 
their ability to activate adenylate cyclase. Adenylate cyclase 
activation and hormone binding were measured on the 
same preparation under identical conditions. While activation 
with [ Lys’] vasopressin exhibited marked negative 
co-operativity and a Hill coefficient of n = 0.35, binding 
did not, or was positively co-operative with a Hill coefficient 
of 1.42 (See also: [4] ). Consequently, the apparent KM value 
for adenylate cyclase activation in pig kidney membranes 
with [Lys”] vasopressin was 3 X lO_” M whereas the 
apparent KM value for binding was about 100 times 
greater, i.e.: 2 X 10.“M. Obviously, with hormones such as 
vasopressin or analogues therefrom which activate in a 
negative co-operative manner higher concentrations are 
required for saturation of binding sites than for adenylate 
cyclase activation. This may be interpreted to mean 
occurrence of’spare receptors. But analogues exhibiting 
different degrees of negative co-operativity activated 
adenykdte cyclase to the same maximal extent and all 
active analogues tested completely displaced [ Lys”] 
vasopressin. Thus, this possibility was considered unlikely 
and it was concluded that this hormone binds reversibly 
to a homogenous population of binding sites all of which 
are involved in adenylate cyclase activation. No binding 
sites linked to other physiological functions aside from 
adenylate cyclase activation were detected. Oxytocin binds 
at least 100 times less tightly than vasopressin [ 5 ] . 
Maximal activation of adenylate cyclase by oxytocin was 
about 80% of that with [ Lys’] vasopressin. The Hill 
coefficients for adenylate cyclase activation and binding 
of oxytocin approached 1.0 and the apparent KM values 
for activation and binding were nearly identical. 
This comparative study suggests that low affinity 
peptide hormones activate in a linear fashion whereas 
those with high affinity for receptor sites activate 
in a nonlinear co-operative manner. The latter need 
only to occupy a part of the total available receptor 
sites in order to elicit maximal adenylate cyclase 
activation. 
Negative co-operative interactions [ 13,141 among 
hormone binding sites on the cell surface would be 
biologically important because they facilitate 
dissociation of tight hormone-receptor complexes 
with increasing hormone concentrations. Furthermore, 
negative co-operativity buffers adenylate cyclase 
against acute changes in circulating hormone 
concentrations. In these instances, the steady state 
concentration rather than rapid fluctuations in the 
amount of circulating hormone would limit the 
biological action. The steady state concentration 
determines the extent of loading of receptors ready 
for biological action. But so long as hormone-receptor 
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interactions are not better defined molecularly, 
negative co-operativity can not be proved. Therefore 
at present negative co-operative interactions among 
hormone binding sites should only be considered as 
a plausible, albeit attractive, possibility. 
4. Control of coupling 
In cases where hormones - i.e.: growth hormone 
and neurohypophyseal hormones - bind to receptors 
in a non-cooperative (or even in a positive cooperative) 
manner but activate in a negative co-operative manner, 
one should look for regulatory control at a step or 
steps beyond the hormone-receptor interaction. 
Although the binding of hormone to receptor is 
essential for the activation of adenylate cyclase or for 
other biological actions, factors which control the 
coupling between liganded hormone receptor and 
adenylate cyclase could detemine how many of the 
hormone-receptor complexes are translated into 
biological function. 
It has been suggested recently that the hormone-receptor 
complex is mobile and moves on or in the fluid membrane. 
Coupling would thus be a stochastic process depending on 
the probability of collision between the mobile hormone- 
receptor complex and a likewise mobile adenylate cyclase, 
cf [ 31. The probability of encounter would be. influenced by 
changes in the liquid-crystalline state of the membrane. 
Unspecific means unrelated to specific hormone effects can 
alter membrane fluidity and could conceivably affect the 
coupling reaction: temperature, pH, cations, changes in 
membrane lipids and cholesterol etc. Although such general 
alterations may occur they would not seem especially 
suited for specific rapid rate control of hormonally 
activated adenylate cyclase in homoiothermic membranes. 
Moreover, lipid halos surrounding the coupling proteins 
might shield them from fluctuations of membrane fluidity. 
Protein and lipid could form a structural and functional 
unit. Among specific factors guanylnucleotides have 
recently received much attention as possible modulators of 
the coupling reaction. Guanylnucleotides appear to play a 
rather universal role in amplification of hormonal activation 
of adenylate cyclases. They could act at a step removed from 
the hormone-receptor interaction [ 151. This has recently 
been discussed in detail, cf [2,15]. Another effector is 
Ca” which may play an even more universal role as 
modulator. In some systems, Cal+ appears to act as another 
second messenger which is independent of or interdependent 
with CAMP [ 16,171. In other systems, for example in brain, 
Cal+ bound to a specific protein may control adenylate 
cyclase activity itself [ 181. Additional effecters and feed 
back modulators of adenylate cyclase activity can be 
anticipated [ 19-211. 
5. Translation of hormone-receptor interactions 
Let us now consider how hormone receptor inter- 
actions are translated into biological function: 
Some (if not all hormones) have pleiotropic 
biological actions: binding to one type of specific 
receptor in the membrane may elicit several seemingly 
unrelated effects. In some but not all cases these 
effects might be mediated by 3’$-CAMP-dependent 
protein kinases with broad substrate specificities [22], 
although the relationships of protein phosphorylation 
to biological effects of hormones are still a matter of 
speculation [2]. 
Another possible explanation for different 
biological actions arising from one and the same 
hormone-receptor interaction would be functional 
links by means of multiple coupling reactions of the 
same liganded hormone receptor or the assumption 
that membrane binding sites which have the same 
specificity and affinity for a horpone are structurally 
linked to different proteins and enzymes. In both 
cases coupling would require a remarkable lack of 
specificity of the interacting proteins. This would 
make actin-like proteins, like the microfilaments in 
membranes attractive candidates for multiple 
coupling reactions. Actins are remarkably 
unselective in choosing their partner. They combine 
with themselves but also with troponins, heavy 
meromyosins, tropomyosin, DNAase I, fibrin, and 
perhaps with glycolytic enzymes. 
Next let us consider cells which have receptors for 
more than one hormone: When hormone receptor 
and adenylate cyclase are coupled nonlinearly 
activation of adenylate cyclase with several hormones 
should not be additive and only limited by the number 
of available adenylate cyclase molecules in the 
membrane pool. This actually seems to be the case, 
cf [2]. Since additive activation would be anticipated 
when each hormone couples stoichiometrically with 
its own adenylate cyclase, nonadditive activation 
and nonlinear coupling also support the idea that 
receptor and adenylate cyclase are separate entities 
in association-dissociation equilibria which interact 
functionally. 
Therefore, one of the questions which need to be 
answered is whether hormone-receptor interactions can be 
uncoupled from adenylate cyclase and perhaps other 
membrane systems. There are many ways to uncouple 
3 
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Scheme 1. Hormone-receptor interactions cause formation of clusters of liganded hormone receptors. Cluster formation and 
coupling with adenylate cyclase is modulated by negative co-operativity. 
A: 
0 
I. Unliganded receptor. 
il II. Uncoupled, hormonally non-stimulated adenylate cyclase. 
B: 0 Liganded receptor. 
II. and III. Partially liganded hormone-receptor adenylate cyclase complexes. IV. The fully liganded hormone-receptor 
adenylate cyclase complex loses affinity because of negatively co-operative interactions and partially dissociates: 
IVA 11+1 Y- --- 
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hormonal activation of adenylate cyclase [23] but there is 
no experiment of which I am aware, which would allow one 
to decide whether uncoupling involves dissociation of an 
intact hormone-receptor adenylate cyclase complex or 
whether it is a consequence of desensitization of adenylate 
cyclase against he hornione, a phenomenon quite common 
with allosterically regulated enzymes. The use of somatic 
cell hybrids deprived of one or the other component should 
help to answer that question [24,25]. 
The questions which I have raised focus on the 
translation of hormone-receptor interactions into 
biological function and specifically adenylate cyclase 
activation. Hypothetical control steps are summarized 
schematically. Perhaps, some of the suggestions I have 
made will stimulate new experiments on signal 
transmission from hormone receptors which is the 
key to the function of hormones. 
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